在婴儿中成功治疗体外膜氧化诱导的数字缺血症,使用甲型玻尿素毒素治疗
Samantha Huang1, Dominick Byrd, Avra Laarakker
1From the Division of Plastic, Reconstructive, Hand and Burn Surgery, Department of Surgery, University of New Mexico, Albuquerque, New Mexico.
概括
毒素A型 (BTX-A) 在体外膜氧化疗法 (ECMO) 后为婴儿和儿童的数字缺血提供安全有效的治疗方法,改善血液循环并预防肢体损失.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 新生儿医学 新生儿医学
- 血管外科 血管外科
背景情况:
- 数字缺血是新生儿和儿童体外膜氧化疗法 (ECMO) 的严重并发症.
- 一种类型A的毒素 (BTX-A) 已在治疗雷诺现象的成年人数字缺血症方面表现出有效性.
研究的目的:
- 评估BTX-A在治疗ECMO治疗后儿科和新生儿患者的数字缺血的安全性和有效性.
- 在年轻患者群体中描述这种非标签治疗的临床结果.
主要方法:
- 三名儿科和新生儿患者在ECMO后出现数字缺血症的回顾性病例系列.
- 对受影响的四肢进行BTX-A注射 (25-50单位),针对动脉解剖学.
- 在注射后进行了对缺血变化和并发症的临床评估.
主要成果:
- 这三名患者在BTX-A注射后24小时内都显示出缺血变色的改善.
- 两名患者在3周内经历了数字缺血症几乎完全消失的情况.
- 在治疗期间没有观察到任何并发症,包括数字损失.
结论:
- 一种类型A型的毒素是一种安全有效的非标签治疗,用于ECMO后儿科和新生儿患者的数字缺血.
- 早期临床改善和缺血症的消失表明BTX-A是一种有前途的治疗选择.
- 需要进一步的研究来证实这些发现在更大的儿科队伍中.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
767
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
767
Skeletal Muscle Relaxants: Therapeutic Uses
622
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
622


